Establishment of syngeneic murine model for oral cancer therapy-Reference-Cited by-同舟云学术

Establishment of syngeneic murine model for oral cancer therapy

Published:2019-08 Issue: Volume:95 Page:194-201
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Chen Yi-Fen,Chang Kuo-Wei,Yang I-Ting,Tu Hsi-Feng^ORCID,Lin Shu-Chun

Funder

Ministry of Science and Technology, Taiwan

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference33 articles.

1. Current mouse models of oral squamous cell carcinoma: Genetic and chemically induced models;Ishida;Oral Oncol,2017

2. The effect of a carcinogen (Dmba) applied to the hamster's buccal pouch in combination with croton oil;Silberman;Oral Surg Oral Med Oral Pathol,1963

3. Nimbolide upregulates RECK by targeting miR-21 and HIF-1alpha in cell lines and in a hamster oral carcinogenesis model;Kowshik;Sci Rep,2017

4. p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas;Chang;Carcinogenesis,1996

5. Establishment and characterization of a cell line (HCDB-1) derived from a hamster buccal pouch carcinoma induced by DMBA and Taiwanese betel quid extract;Lin;Proc Natl Sci Counc Repub China B,2000

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NIR-II photothermal therapy mediated by polymer-based nanoparticles to enhance checkpoint inhibitor immunotherapy for inhibiting lymph node metastasis in oral squamous cell carcinoma;Nano Today;2024-08

2. The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas;Journal of Dental Sciences;2024-07

3. The high expression of immune checkpoint co-stimulators predicts a favorable prognosis in head and neck carcinomas;2024-03-14

4. Development of an integrated dual-modality 3D bioluminescence tomography and ultrasound imaging system for small animal tumor imaging;Optics Express;2024-02-01

5. FAP is a prognostic marker, but not a viable therapeutic target for clinical translation in HNSCC;Cellular Oncology;2023-10-19